首页> 外国专利> METHOD FOR INDIRECT REGIONAL LYMPHOTROPIC CHEMOTHERAPY IN INFILTRATIVE, DESTRUCTIVE AND DRUG-RESISTANT PULMONARY TUBERCULOSIS

METHOD FOR INDIRECT REGIONAL LYMPHOTROPIC CHEMOTHERAPY IN INFILTRATIVE, DESTRUCTIVE AND DRUG-RESISTANT PULMONARY TUBERCULOSIS

机译:感染性,破坏性和耐药性肺结核间接区域淋巴化疗的方法

摘要

FIELD: medicine, phthisiology.;SUBSTANCE: method involves firstly the achievement of lymphotropicity of three chemopreparations by addition of 5% glucose and aloe to solutions of these chemopreparations. Then the conduction paravertebral anesthesia is carried out at the level and at side of administration of preparations. Then three chemopreparations are administrated separately in different intercostals sites, 1-3 times per a week, course of 4-12 injections by subcutaneous paravertebral route, parasternal route in I-X intercostals - in projection of regional lymphatic collectors. Method allows reducing the duration of intensive phase in tuberculosis treatment up to 1-3-6 months, to prevent the development of drug-resistant tuberculosis and adverse effects of chemopreparations and to relieve the residual changes of tuberculosis. Invention can be used in treatment of infiltrative, destructive and drug-resistant pulmonary tuberculosis.;EFFECT: improved and enhanced method of treatment.;2 ex
机译:领域:医学,生理学;实质:该方法首先涉及通过向这些化学制剂的溶液中添加5%葡萄糖和芦荟来实现三种化学制剂的疏水性。然后在制剂给药的水平和侧面进行传导性椎旁麻醉。然后在不同的肋间部位分别进行三种化学制剂的给药,每周1-3次,通过皮下椎旁途径,I-X肋间的胸骨旁途径进行4至12次注射,以预测局部淋巴收集者。该方法可以将结核病强化治疗的持续时间缩短至1-3-6个月,以防止耐药性结核病的发展和化学制剂的不利影响,并减轻结核病的残留变化。本发明可用于治疗浸润性,破坏性和耐药性的肺结核。效果:改进和增强的治疗方法。2

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号